Roger D. Norcross

Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis

Mark B. Pepys, J. Herbert, W. L. Hutchinson et al. · Nature · 2002 · 536 citations

Alzheimer's Disease, Medicine, Pharmacological Depletion +5

TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity

Florent G. Revel, Jean‐Luc Moreau, Raul R. Gainetdinov et al. · Proceedings of the National Academy of Sciences · 2011 · 362 citations · Full text

A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight

F. Revel, J‐L Moreau, Bruno Pouzet et al. · Molecular Psychiatry · 2012 · 285 citations

Psychoactive Drug, Psychiatry, Psychotic Disorder +13

<i>C</i>₂‐Symmetric Cationic Copper(<scp>II</scp>) Complexes as Chiral Lewis Acids: Counterion Effects in the Enantioselective Diels–Alder Reaction

David A. Evans, Jerry A. Murry, Peter Matt et al. · Angewandte Chemie International Edition in English · 1995 · 285 citations

Enantioselective Diels–alder Reaction, Chemical Engineering, Enantioselective Synthesis +12

Enantio- and diastereoselective aldol reactions of achiral ethyl and methyl ketones with aldehydes: the use of enol diisopinocampheylborinates

Ian Paterson, Jonathan M. Goodman, M. A. LISTER et al. · Tetrahedron · 1990 · 269 citations

Achiral Ethyl, Enol Diisopinocampheylborinates, Biochemistry +5